HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS

Authors
DAHAN R JAILLON P LEHNER JP CAZOR JL CLOARECBLANCHARD L DAHAN R DUCHIER J GUINOT P JAILLON P LEHNER JP LOEB F MACQUINMAVIER C PUECH A ROLAND E ROUVEIX B TEULEESPIE M THULLIEZ C VITOU P
Citation
R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301
Citations number
3
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Therapie → ACNP
ISSN journal
00405957
Volume
48
Issue
4
Year of publication
1993
Pages
297 - 301
Database
ISI
SICI code
0040-5957(1993)48:4<297:HTPTTD>2.0.ZU;2-W